Alerts
Holiday Hours Information

In recognition of the Christmas and New Year’s holidays, some of The University of Kansas Cancer Center’s offices will have modified hours on Wednesday, December 25, and Wednesday, January 1.

Skip Navigation

An Expanded Access Program for the non-invasive detection of clear cell renal cell carcinoma ccRCC in patients with renal masses utilizing Zirconium-labelled girentuximab 89Zr-DFO-girentuximab

Brief Summary

Type:
Kidney

Study Type:
Diagnostic

Phase:
N/A

ClinicalTrials.gov Identifier:
NCT06090331

Study #:
STUDY00160068

Start Date:
Aug 11, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06090331

View Complete Trial Details & Eligibility at ClinicalTrials.gov